Latest Capital Raises News

Banco Santander has launched A$550 million of fixed rate senior notes due in 2031, exclusively aimed at professional and eligible counterparties under MiFID II regulations. The notes will be listed on the ASX and carry investment-grade ratings.

Alicanto Minerals Limited has announced a 12-for-1 consolidation of its securities, including ordinary shares, performance rights, and options, effective from late January 2026. This move will significantly reduce the number of securities on issue and adjust option exercise prices accordingly.

Finder Energy has completed a $5.2 million capital raise through a share placement to its directors and substantial shareholder Longreach Capital, following shareholder approval.

Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.

Westar Resources reported significant progress in its December 2025 quarterly activities, including new tenement grants and advanced data acquisition at key gold and copper projects. The company also completed a partial capital raise, positioning itself for further exploration.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Eagle Mountain Mining has issued nearly 120 million new shares and 40 million options, raising just over $1 million, but a significant shortfall remains to be placed. The company aims to secure additional funding to advance its Arizona copper-gold projects.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

APC Minerals Limited has raised $264,000 through a discounted top-up placement of 66 million shares, enhancing its financial capacity to pursue new and existing projects.

Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.

Dalaroo Metals’ maiden sampling at Blue Lagoon reveals a district-scale critical minerals system with high-grade zirconium, hafnium, and rare earth elements over a 2.7km strike. The results validate historical data and position the project as a strategic asset in Greenland’s emerging critical minerals landscape.

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.